Title:
NOVEL RECOMBINANT PCV2D ANTIGEN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/096648
Kind Code:
A1
Abstract:
The present invention relates to a novel recombinant PCV2d antigen and a use thereof, wherein an ORF2 sequence of the existing PCV2 is subjected to codon and vector optimization so as for the sequence to be expressed in insect cells, and an optimal culture method is applied to increase the protein yield, thereby allowing for widespread use in the prevention of porcine circovirus infectious diseases.
Inventors:
OH JONG MIN (KR)
CHOI JAE BANG (KR)
YOON BIT NA RAE (KR)
PARK SANG MI (KR)
LEE JI HOON (KR)
OH MI KYOUNG (KR)
HAN BEOM KU (KR)
KIM HYUN IL (KR)
CHOI JAE BANG (KR)
YOON BIT NA RAE (KR)
PARK SANG MI (KR)
LEE JI HOON (KR)
OH MI KYOUNG (KR)
HAN BEOM KU (KR)
KIM HYUN IL (KR)
Application Number:
PCT/KR2023/017451
Publication Date:
May 10, 2024
Filing Date:
November 03, 2023
Export Citation:
Assignee:
OPTIPHARM CO LTD (KR)
International Classes:
C07K14/005
Attorney, Agent or Firm:
JUNGJIN IP LAW FIRM (Guro-gu, Seoul, KR)
Download PDF:
Previous Patent: TRAILER FOR MOBILE HOME
Next Patent: ANODE ACTIVE MATERIAL, PREPARATION METHOD THEREFOR AND LITHIUM SECONDARY BATTERY COMPRISING SAME
Next Patent: ANODE ACTIVE MATERIAL, PREPARATION METHOD THEREFOR AND LITHIUM SECONDARY BATTERY COMPRISING SAME